Funded Early Detection and Screening Grants

Active/Completed

Topics

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Chinnaiyan, Arul M	University Of Michigan At Ann Arbor United States	Michigan-VUMC Biomarker Characterization Center	5U2CCA271854-03	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Cocucci, Emanuele	Ohio State University United States	A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL	5R01CA270251-03	Matthew Young, Ph.D.
Cook, Linda S	University Of Colorado Denver United States	NOT-CA-24-111 Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)	3UG1CA286941-02S1	Elyse LeeVan, M.D., M.P.H.
Counter, Christopher M	Duke University United States	Adapting K-MDS to detect KRAS-mutant ctDNA	5R21CA257816-03
Davis, Jennifer Sarah	University Of Kansas Medical Center United States	Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype	7U01CA222163-04	Claire Zhu, Ph.D.
Debes, Jose Daniel	University Of Minnesota United States	Biomarkers for Early Detection of Hepatitis B-Related Hepatocellular Carcinoma in Hispanics	1R37CA297814-01	Sidney Fu, M.D.
Demb, Joshua Brian	University Of California, San Diego United States	Optimal early colorectal cancer screening initiation	4R00CA267181-03	Claire Zhu, Ph.D.
Deng, Youping	University Of Hawaii At Manoa United States	Profiling genome-wide circulating ncRNAs for the early detection of lung cancer	5R01CA223490-05
Deng, Youping	University Of Hawaii At Manoa United States	Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms	5R01CA230514-05	Christos Patriotis, Ph.D., M.Sc.
Dhakal, Soma	Virginia Commonwealth University United States	Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers	5R61CA278445-03	Christos Patriotis, Ph.D., M.Sc.
Diaz, Juan Sebastian Gomez	University Of California At Davis United States	A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids	5R01CA273253-03
Digirolamo, Gregory James	Univ Of Massachusetts Med Sch Worcester United States	Increasing Nodule Detection in Lung Cancer by Non-Conscious Detection of "Missed" Nodules and Machine Learning	5R01CA269903-04	Richard Mazurchuk, Ph.D.
Doescher, Mark P	University Of Oklahoma Hlth Sciences Ctr United States	Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub	3UG1CA287044-02S1	Elyse LeeVan, M.D., M.P.H.
Drake, Richard R.	Medical University Of South Carolina United States	Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids	5R33CA267226-03	Richard Mazurchuk, Ph.D.
Eastham, James A	Sloan-Kettering Inst Can Research United States	Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers	5U01CA266535-03	Claire Zhu, Ph.D.